CELYAD ONCOLOGY SA Profit Loss From Operating Activities
CELYAD ONCOLOGY SA reported Profit Loss From Operating Activities of -EUR 3.75 million for the 6-month period ending 2023-06-30, per its 6-K filed 2023-09-05.
Discontinued › Cash Flow › Operating Activities
ifrs-full:ProfitLossFromOperatingActivities · last filed 2023-09-05
| Period end | Profit Loss From Operating Activities 6 month | Profit Loss From Operating Activities 12 month |
|---|---|---|
| 2023-06-30 | -3.75M EUR 6-K · filed 2023-09-05 | |
| 2022-12-31 | -40.86M EUR 20-F · filed 2023-03-23 | |
| 2022-06-30 | -14.08M EUR 6-K · filed 2023-09-05 | |
| 2021-12-31 | -26.39M EUR 20-F · filed 2023-03-23 | |
| 2021-06-30 | -14.88M EUR 6-K · filed 2022-08-05 | |
| 2020-12-31 | -16.99M EUR 20-F · filed 2023-03-23 | |
| 2020-06-30 | -16.55M EUR 6-K · filed 2021-08-04 | |
| 2019-12-31 | -28.88M EUR 20-F · filed 2022-03-24 | |
| 2019-06-30 | -15.95M EUR 6-K · filed 2020-08-07 | |
| 2018-12-31 | -38.17M EUR 20-F · filed 2021-03-24 | |
| 2018-06-30 | -18.79M EUR 6-K/A · filed 2019-09-05 | |
| 2017-12-31 | -52.88M EUR 20-F · filed 2020-03-25 | |
| 2016-12-31 | -25.61M EUR 20-F · filed 2019-04-05 |